European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on November 3, 2026

Nov. 3, 2026

Dynacor Group Announces US$20 Million Gold Purchase and Prepayment Facility

Indeterminate GlobeNewswire

Nov. 3, 2026

Groupe Dynacor annonce une facilité d’achat et de prépaiement d’or de 20 M$ US

Indeterminate GlobeNewswire

Nov. 3, 2026

Bull et Schwarz Digits, une alliance franco-allemande pour la souveraineté numérique de l’Europe

Indeterminate GlobeNewswire

Nov. 3, 2026

Bull und Schwarz Digits, eine deutsch-französische Allianz für Europas digitale Souveränität

Indeterminate GlobeNewswire

Nov. 3, 2026

Bull and Schwarz Digits, a Franco-German alliance for Europe’s digital sovereignty

Indeterminate GlobeNewswire

Nov. 3, 2026

MUSSO Champions Inclusive Ergonomics for Petite Women with US Black Friday Promotion, Featuring Award-Winning Design

Indeterminate GlobeNewswire

Nov. 3, 2026

Cabaletta Bio to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Avalyn to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

Nov. 3, 2026

Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting

Indeterminate GlobeNewswire

Nov. 3, 2026

Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Septerna to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations

Indeterminate GlobeNewswire

Nov. 3, 2026

Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation

Indeterminate GlobeNewswire

Nov. 3, 2026

Todd Netland Reveals the Real-Life Music Experiences Behind *Fame and Fortune Tellers

Indeterminate EIN Presswire

Nov. 3, 2026

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

One Bullion Reports Significant Historical Gold Results and Advances Exploration at Vumba

Indeterminate GlobeNewswire

Nov. 3, 2026

Kailera Therapeutics to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire